Malignus eredetu nyelocsoszukületek palliatív kezelése endoprotézis beültetésével -- 25 év tapasztalata.

Translated title of the contribution: [Palliative management of malignant oesophageal strictures with endoprosthesis implantation -- 25 years experience].

Akos Balázs, Péter Kokas, Péter Lukovich, P. Kupcsulik

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this study was to analyse the feasibility of the use of oesophageal endoprosthesis based on a large series of cases. 2952 malignant oesophageal strictures managed between 1984 and 2009 were analysed. While surgical intubation was carried out in 42 patients, endoscopic implantation was feasible in 1143 cases. Patients not eligible for oesophageal stenting were treated with gastrostomy in 125, percutaneous endoscopic gastrostomy in 19, catheter jejunostomy in 9 and supportive therapy in 965 cases, respectively. Endoprosthesis could have been inserted in 61.2% of the patients. Dysphagia was terminated temporarily in 6.2% and permanently in 93.5%. Complications were detected in 23.7% of the cases, which included stent migration, perforation, bleeding, airway obstruction, early unexpected death, aspiration, stent obstruction, tumor overgrowth, oesophago-respiratory fistula formation and neoformation, and reflux. Complications were treated endoscopically primarily (69.2%). Lethal complication rate was 2.1% (27 cases). Furthermore, complication rate of patients who underwent surgical stent insertion was 21.9%. Mean survival of patients with oesophageal intubation was 5.4 months, with nutritional support via gastrostomy, percutaneous endoscopic gastrostomy or jejunostomy 3.6 months and with supportive therapy alone 3.2 months. Oesophageal endoprosthesis insertion is an effective method for the palliative management of malignant oesophageal strictures. Stent implantation improves survival as well as quality of life. Methods used for nutritional support decreases hungriness but do not influence survival.

Original languageHungarian
Pages (from-to)267-276
Number of pages10
JournalMagyar sebészet
Volume64
Issue number6
Publication statusPublished - Dec 2011

Fingerprint

Esophageal Stenosis
Gastrostomy
Stents
Jejunostomy
Nutritional Support
Intubation
Survival
Airway Obstruction
Deglutition Disorders
Fistula
Catheters
Quality of Life
Hemorrhage
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Malignus eredetu nyelocsoszukületek palliatív kezelése endoprotézis beültetésével -- 25 év tapasztalata. / Balázs, Akos; Kokas, Péter; Lukovich, Péter; Kupcsulik, P.

In: Magyar sebészet, Vol. 64, No. 6, 12.2011, p. 267-276.

Research output: Contribution to journalArticle

@article{b3f40a879e6344f2bdef367d38379b2a,
title = "Malignus eredetu nyelocsoszuk{\"u}letek palliat{\'i}v kezel{\'e}se endoprot{\'e}zis be{\"u}ltet{\'e}s{\'e}vel -- 25 {\'e}v tapasztalata.",
abstract = "The aim of this study was to analyse the feasibility of the use of oesophageal endoprosthesis based on a large series of cases. 2952 malignant oesophageal strictures managed between 1984 and 2009 were analysed. While surgical intubation was carried out in 42 patients, endoscopic implantation was feasible in 1143 cases. Patients not eligible for oesophageal stenting were treated with gastrostomy in 125, percutaneous endoscopic gastrostomy in 19, catheter jejunostomy in 9 and supportive therapy in 965 cases, respectively. Endoprosthesis could have been inserted in 61.2{\%} of the patients. Dysphagia was terminated temporarily in 6.2{\%} and permanently in 93.5{\%}. Complications were detected in 23.7{\%} of the cases, which included stent migration, perforation, bleeding, airway obstruction, early unexpected death, aspiration, stent obstruction, tumor overgrowth, oesophago-respiratory fistula formation and neoformation, and reflux. Complications were treated endoscopically primarily (69.2{\%}). Lethal complication rate was 2.1{\%} (27 cases). Furthermore, complication rate of patients who underwent surgical stent insertion was 21.9{\%}. Mean survival of patients with oesophageal intubation was 5.4 months, with nutritional support via gastrostomy, percutaneous endoscopic gastrostomy or jejunostomy 3.6 months and with supportive therapy alone 3.2 months. Oesophageal endoprosthesis insertion is an effective method for the palliative management of malignant oesophageal strictures. Stent implantation improves survival as well as quality of life. Methods used for nutritional support decreases hungriness but do not influence survival.",
author = "Akos Bal{\'a}zs and P{\'e}ter Kokas and P{\'e}ter Lukovich and P. Kupcsulik",
year = "2011",
month = "12",
language = "Hungarian",
volume = "64",
pages = "267--276",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "6",

}

TY - JOUR

T1 - Malignus eredetu nyelocsoszukületek palliatív kezelése endoprotézis beültetésével -- 25 év tapasztalata.

AU - Balázs, Akos

AU - Kokas, Péter

AU - Lukovich, Péter

AU - Kupcsulik, P.

PY - 2011/12

Y1 - 2011/12

N2 - The aim of this study was to analyse the feasibility of the use of oesophageal endoprosthesis based on a large series of cases. 2952 malignant oesophageal strictures managed between 1984 and 2009 were analysed. While surgical intubation was carried out in 42 patients, endoscopic implantation was feasible in 1143 cases. Patients not eligible for oesophageal stenting were treated with gastrostomy in 125, percutaneous endoscopic gastrostomy in 19, catheter jejunostomy in 9 and supportive therapy in 965 cases, respectively. Endoprosthesis could have been inserted in 61.2% of the patients. Dysphagia was terminated temporarily in 6.2% and permanently in 93.5%. Complications were detected in 23.7% of the cases, which included stent migration, perforation, bleeding, airway obstruction, early unexpected death, aspiration, stent obstruction, tumor overgrowth, oesophago-respiratory fistula formation and neoformation, and reflux. Complications were treated endoscopically primarily (69.2%). Lethal complication rate was 2.1% (27 cases). Furthermore, complication rate of patients who underwent surgical stent insertion was 21.9%. Mean survival of patients with oesophageal intubation was 5.4 months, with nutritional support via gastrostomy, percutaneous endoscopic gastrostomy or jejunostomy 3.6 months and with supportive therapy alone 3.2 months. Oesophageal endoprosthesis insertion is an effective method for the palliative management of malignant oesophageal strictures. Stent implantation improves survival as well as quality of life. Methods used for nutritional support decreases hungriness but do not influence survival.

AB - The aim of this study was to analyse the feasibility of the use of oesophageal endoprosthesis based on a large series of cases. 2952 malignant oesophageal strictures managed between 1984 and 2009 were analysed. While surgical intubation was carried out in 42 patients, endoscopic implantation was feasible in 1143 cases. Patients not eligible for oesophageal stenting were treated with gastrostomy in 125, percutaneous endoscopic gastrostomy in 19, catheter jejunostomy in 9 and supportive therapy in 965 cases, respectively. Endoprosthesis could have been inserted in 61.2% of the patients. Dysphagia was terminated temporarily in 6.2% and permanently in 93.5%. Complications were detected in 23.7% of the cases, which included stent migration, perforation, bleeding, airway obstruction, early unexpected death, aspiration, stent obstruction, tumor overgrowth, oesophago-respiratory fistula formation and neoformation, and reflux. Complications were treated endoscopically primarily (69.2%). Lethal complication rate was 2.1% (27 cases). Furthermore, complication rate of patients who underwent surgical stent insertion was 21.9%. Mean survival of patients with oesophageal intubation was 5.4 months, with nutritional support via gastrostomy, percutaneous endoscopic gastrostomy or jejunostomy 3.6 months and with supportive therapy alone 3.2 months. Oesophageal endoprosthesis insertion is an effective method for the palliative management of malignant oesophageal strictures. Stent implantation improves survival as well as quality of life. Methods used for nutritional support decreases hungriness but do not influence survival.

UR - http://www.scopus.com/inward/record.url?scp=84859923560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859923560&partnerID=8YFLogxK

M3 - Article

C2 - 22169339

AN - SCOPUS:84859923560

VL - 64

SP - 267

EP - 276

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 6

ER -